Full Text:


The article describes some inherited disorders (Marfan syndrome, Ehlers-Danlos syndrome, Osler-Weber-Rendu disease) that affects the connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems during the pregnancy. The present article aims to provide an overview of these rare but very important hereditary disorders. Diagnosing of these disorders can be difficult because the symptoms can vary significantly from person to person. There are clinical criteria and molecular methods of diagnostics. The pathogenesis of these inherited connective tissue disorders has not been fully elucidated. Pregnancy can be dangerous in such patients due to the high risk of lifetreating complications. Cesarean section is preferred in women with inherited connective tissue disorders.

About the Author

L. S. Radetskaya
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation
MD, docent of the Department of Obstetrics and Gynecology


1. Barkagan Z.S. Hemorrhagic diseases and syndromes [Gemorragicheskie zabolevaniya i sindromy (In Russian)]. Moscow. 1988; 526 s.

2. Kulakov V.I., Serov V.N., Abubakirova A.M., Baranov I.I. Obstetric hemorrhage [Akusherskie krovotecheniya (In Russian)]. Moscow. 1998.

3. Makatsariya A.D., Belenkov Yu.N., Beilin A.L. Pregnancy and congenital heart disease [Beremennost' i vrozhdennye poroki serdtsa (In Russian)]. Moscow. 2001; 416 s.

4. Serov V.N., Makatsariya A.D. Thrombotic and hemorrhagic complications in obstetrics [Tromboticheskie i gemorragicheskie oslozhneniya v akusherstve (In Russian)]. Moscow. 1987; 288 s.

5. Sukhanova G.A. Identification and correction of hemostasis in mesenchymal dysplasia. PhD. Diss. [Vyyavlenie i korrektsiya narushenii gemostaza pri mezenkhimal'nykh displaziyakh. Diss. …kand. med. nauk (In Russian)]. Barnaul. 1993.

6. Fomina I.G. Makarov I.E. Prokof'eva E.B. Klinich. meditsina. 2001; 79 (6): 52-55.

7. Abdalla S.A., Pece-Barbara N., Vera S., Tapia E., Paez E., Bernabeu C., Letarte M. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet. 2000 May 1; 9 (8): 1227-37.

8. Abdalla S.A., Geithoff U.W., Bonneau D., Plauchu H. et al. Visceral manifestations in hereditary hemorrhagic telangiectasia type 2. J Med Genet. 2003; 40: 494-502.

9. Aburawi E.H., O'Sullivan J., Hasan A. Marfan's syndrome: a review. Hosp Med. 2001 Mar; 62 (3): 153-7.

10. Adam H., Radow L. Anesthesia for section caesarean with aortic dissection in Marfan Syndrome. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 Oct; 37 (10): 630-5.

11. Akashi H., Tayama K., Fujino T., Onitsuka S., Sakashita H., Aoyagi S. Surgical treatment for acute type A aortic dissection in pregnancy: a case of aortic root replacement just after Cesarean section. Jpn Circ J. 2000 Sep; 64 (9): 729-30.

12. Andelfinger G., Shirali G.S., Raunikar R.A., Atz A.M. Functional pulmonary atresia in neonatal Marfan's syndrome: successful treatment with inhaled nitric oxide. Pediatr Cardiol. 2001 Nov-Dec; 22 (6): 525-6. Epub 2001 Dec 04.

13. Ben Letaifa D., Slama A., Methamem M., Ben Jazia K., Jegham H. Anesthesia for cesarean section in a Marfan patient with complicated aortic dissection. Ann Fr Anesth Reanim. 2002 Oct; 21 (8): 672-5.

14. Bick R. Vascular thrombohemorrhagic disorders: hereditary and acquired. Clin Appl Thromb Hemost. 2001 Jul; 7 (3): 178-94.

15. Brar H.B. Anaesthetic management of a caesarean section in a patient with Marfan's syndrome and aortic dissection. Anaesth Intensive Care. 2001 Feb; 29 (1): 67-70.

16. Burrows N.P. The molecular genetics of the Ehlers-Danlos Syndrome. Clin Experim Dermatol. 1999; 24: 99-106.

17. Child A.H. Marfan syndrome--current medical and genetic knowledge: how to treat and when. J Card Surg. 1997 Mar-Apr; 12 (2): 131-5; discussion 135-6.

18. Colman J.M., Sermer M., Seaward P.G., Siu S.C. Congenital heart disease in pregnancy. Cardiol Rev. 2000 May-Jun; 8 (3): 166-73.

19. Dean J.C. Management of Marfan syndrome. Heart. 2002 Jul; 88 (1): 97-103.

20. Dominiq P.G. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Annals of vascular surgery. May 2002.

21. Draca S. Is pregnancy a model how we should control some autoimmune diseases? Autoimmunity. 2002 Aug; 35 (5): 307-12.

22. Mayet J., Steer P., Somerville J. Marfan syndrome, aortic dilatation, and pregnancy. Obstet Gynecol. 1998 Oct; 92 (4 Pt 2): 713.

23. Figueiredo S., Martins E., Lima M.R., Alvares S. Cardiovascular manifestations in Marfan syndrome. Rev Port Cardiol. 2001 Dec; 20 (12): 1203-18.

24. Guttmaher A.E., Marchuk D.A., White R. Hereditary hemorrhagic telangiectasia. Current cncepts. The New England Journal of Medicine. 1995; 333 (14): 918-925.

25. Heather N.Y., Walker L.C. Mutations in the lysil hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Molecular genetics and metabolism. 2002; 71: 212-224.

26. Jakobi P., Weiner Z., Best L., Itskovitz-Eldor J. Hereditary hemorrhagic telangiectasia with pulmonary arteriovenous malformations. Obstet Gynecol. 2001 May; 97 (5 Pt 2): 813-4.

27. Jerez Matas A.L., Sahagun de la Lastra J., Diaz Jimenez J. Epidural anesthesia for cesarean section in a patient with Marfan syndrome. Rev Esp Anestesiol Reanim. 2000 Mar; 47 (3): 134.

28. Jondeau G., Nataf P., Belarbi A., Farcot J.C., Iung B., Delorme G., Gandjbakhch I., Bourdarias J.P. Aortic dissection at 6 months gestation in a women with Marfan's syndrome. Masui. 2002 Aug; 51 (8): 916-20.

29. Khurshid I., Downie G.H. Pulmonary arteriovenous malformation. Postgrad Med J. 2002; 78: 191-197.

30. Von Kodolitsch Y., Raghunath M., Karck M., Haverich A., Nienaber C.A. Marfan syndrome: therapy of cardiovascular manifestations. Z Kardiol. 1998 Mar; 87 (3): 173-84.

31. Von Kodolitsch Y., Raghunath M., Nienaber C.A. Marfan syndrome: prevalence and natural course of cardiovascular manifestations. Z Kardiol. 1998 Mar; 87 (3): 150-60.

32. Von Kodolitsch Y., Raghunath M., Nienaber C.A. Marfan syndrome: strategies of interdisciplinary care. Dtsch Med Wochenschr. 1998 Jan 2; 123 (1-2): 21-5.

33. Koh M.B., Hunt B.J. The management of perioperative bleeding. Blood Rev. 2003 Sep;17 (3): 179-85.

34. Kohler F., Fotuhi P., Baumann G. Pregnancy and congenital heart defects. Z Kardiol. 2001; 90 (4): 30-5.

35. Lambaudie E., Depret-Mosser S., Occelli B., Papageorgiou T., Dognin A., Bertrand M., de Martinville B., Codaccioni X., Monnier J.C. Marfan syndrome and pregnancy. Apropos of 4 cases. Gynecol Obstet Fertil. 2002 Jul-Aug; 30 (7-8): 567-75.

36. Lind J., Wallenburg H.C. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001 Sep; 98 (1): 28-35.

37. Loeys B., Nuytinck L., Van Acker P., Walraedt S., Bonduelle M., Sermon K., Hamel B., Sanchez A., Messiaen L., De Paepe A. Strategies for prenatal and preimplantation genetic diagnosis in Marfan syndrome (MFS). Prenat Diagn. 2002 Jan; 22 (1): 22-8.

38. Loscalyo J., Schafer A.I. Thrombosis and hemmorage. Williams & Wilkins. 2-nd edition. 1998; 1135-1157.

39. Matsubara Shunji et al. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuradiol. 2000. June/July; 21: 1016-1020.

40. Milewicz D.M. Molecular genetics of Marfan syndrome and Ehlers-Danlos type IV. Curr Opin Cardiol. 1998 May; 13 (3): 198-204.

41. Mobeen I., Rossoff L.J. Pulmonary arteriovenous malformations: a clinical review. Postgrad Med J. 2000; 76: 390-394.

42. Moodie D.S. Diagnosing Marfan syndrome is still based on clinical characteristics. Cleve Clin J Med. 1998 Apr; 65 (4): 176, 179-81.

43. Paternoster D.M., Santarossa C., Vettore N., Dalla Pria S., Grella P. Obstetric complications in Marfan's syndrome pregnancy. Minerva Ginecol. 1998 Oct; 50 (10): 441-3.

44. Preiss M., Hosli I., Holzgreve W., Zerkowski H.R. Aortic dissection in pregnancy in Marfan syndrome-case report and treatment concept. Z Geburtshilfe Neonatol. 2001 May- Jun; 205 (3): 110-3.

45. Rahman J., Rahman F.Z., Rahman W., al-Suleiman S.A., Rahman M.S. Obstetric and gynecologic complications in women with Marfan syndrome. J Reprod Med. 2003 Sep; 48 (9): 723-8.

46. Rantamaki T., Kaitila I., Syvanen A.C., Lukka M., Peltonen L. Recurrence of Marfan syndrome as a result of parental germ-line mosaicism for an FBN1 mutation. Am J Hum Genet. 1999 Apr; 64 (4): 993-1001.

47. Shovlin C.L., Winstock A.R., Peters A.M., Jackson J.E., Hughes J.M. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM. 1995 Dec; 88 (12): 879-87.

48. Sermon K., Lissens W., Messiaen L., Bonduelle M., Vandervorst M., Van Steirteghem A., Liebaers I. Preimplantation genetic diagnosis of Marfan syndrome with the use of fluorescent polymerase chain reaction and the Automated Laser Fluorescence DNA Sequencer. Fertil Steril. 1999 Jan; 71 (1): 163-6.

49. Shovlin C.L., Leterte M. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations:issues in clinical management end review of pathogenic mechanisms. Thorax. 1999; 54: 714-729.

50. Simpson L.L., Athanassious A.M., D'Alton M.E. Marfan syndrome in pregnancy. Curr Opin Obstet Gynecol. 1997 Oct; 9 (5): 337-41.

51. Toudjarska I., Kilpatrick M.W., Lembessis P., Carra S., Harton G.L., Sisson M.E., Black S.H., Stern H.J., Gelman-Kohan Z., Shohat M., Tsipouras P. Novel approach to the molecular diagnosis of Marfan syndrome: application to sporadic cases and in prenatal diagnosis. Am J Med Genet. 2001 Apr 1; 99 (4): 294-302.

52. Uchida T., Ogino H., Ando M., Okita Y., Yagihara T., Kitamura S. Aortic dissection in pregnant woman with the Marfan syndrome . Kyobu Geka. 2002 Jul; 55 (8): 693-6.

53. Wallace G.M., Shovlin C.L. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax. 2000 Aug; 55 (8): 685-90



For citations:


Views: 477

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)